Literature DB >> 11955975

Visual scanpaths to positive and negative facial emotions in an outpatient schizophrenia sample.

Carmel M Loughland1, Leanne M Williams, Evian Gordon.   

Abstract

We used a psychophysiological marker of visual attention (visual scanpath) to investigate facial emotion processing in schizophrenia (n= 65) and healthy control (n = 61) groups. Visual scanpaths to 'happy', *sad' and 'neutral' faces (two exposures each) were recorded using video-oculography. Emotion recognition accuracy was assessed under both 'difficult' (exposure 1) and 'limited choice' (exposure 2) conditions. Compared to controls, schizophrenia subjects showed 'restricted' scanning and reduced attention to salient facial features (eyes, nose, mouth), that was particularly apparent for happy and neutral faces: accuracy was correspondingly reduced for the 'difficult' condition. The schizophrenia deficit in positive emotion perception may reflect a failure to integrate salient features due to dysfunctions in local processing of detailed, relevant information (fewer fixations, less attention to facial features), and in the networks that synchronise local and global processing of biologically-relevant face stimuli (generally restricted scanning style).

Entities:  

Mesh:

Year:  2002        PMID: 11955975     DOI: 10.1016/s0920-9964(01)00186-4

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  46 in total

1.  Visual exploration of emotional facial expressions in Parkinson's disease.

Authors:  Uraina S Clark; Sandy Neargarder; Alice Cronin-Golomb
Journal:  Neuropsychologia       Date:  2010-03-15       Impact factor: 3.139

2.  Perceptual bias of patients with schizophrenia in morphed facial expression.

Authors:  Jia Huang; Raymond C K Chan; Jackie K Gollan; Wenhua Liu; Zheng Ma; Zhanjiang Li; Qi-yong Gong
Journal:  Psychiatry Res       Date:  2010-06-19       Impact factor: 3.222

3.  Guided saccades modulate object and face-specific activity in the fusiform gyrus.

Authors:  James P Morris; Gregory McCarthy
Journal:  Hum Brain Mapp       Date:  2007-08       Impact factor: 5.038

4.  Visual scanning patterns and executive function in relation to facial emotion recognition in aging.

Authors:  Karishma S Circelli; Uraina S Clark; Alice Cronin-Golomb
Journal:  Neuropsychol Dev Cogn B Aging Neuropsychol Cogn       Date:  2012-05-22

5.  Extraction of Emotional Information via Visual Scanning Patterns: A Feasibility Study of Participants with Schizophrenia and Neurotypical Individuals.

Authors:  Joshua Wade; Heathman S Nichols; Megan Ichinose; Dayi Bian; Esube Bekele; Matthew Snodgress; Ashwaq Zaini Amat; Eric Granholm; Sohee Park; Nilanjan Sarkar
Journal:  ACM Trans Access Comput       Date:  2018-11

6.  Emotion-elicited gamma synchrony in patients with first-episode schizophrenia: a neural correlate of social cognition outcomes.

Authors:  Leanne M Williams; Thomas J Whitford; Marie Nagy; Gary Flynn; Anthony W F Harris; Steven M Silverstein; Evian Gordon
Journal:  J Psychiatry Neurosci       Date:  2009-07       Impact factor: 6.186

Review 7.  Atypical scanpaths in schizophrenia: evidence of a trait- or state-dependent phenomenon?

Authors:  Sara A Beedie; Philip J Benson; David M St Clair
Journal:  J Psychiatry Neurosci       Date:  2011-05       Impact factor: 6.186

8.  Restricted attention to social cues in schizophrenia patients.

Authors:  Alexandra Nikolaides; Susanne Miess; Isabella Auvera; Ralf Müller; Joachim Klosterkötter; Stephan Ruhrmann
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-06-15       Impact factor: 5.270

9.  Attentional-shaping as a means to improve emotion perception deficits in schizophrenia.

Authors:  Dennis R Combs; Aneta Tosheva; David L Penn; Michael R Basso; Jill L Wanner; Kristen Laib
Journal:  Schizophr Res       Date:  2008-06-27       Impact factor: 4.939

10.  Structural neurobiological correlates of Mayer-Salovery-Caruso Emotional Intelligence Test performance in early course schizophrenia.

Authors:  Jessica A Wojtalik; Shaun M Eack; Matcheri S Keshavan
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-10-02       Impact factor: 5.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.